#29 · Tools & infrastructure
Integrated pipelines and platforms are consolidating multi-step genomic analyses
The common thread is consolidation of multi-step genomic analysis into end-to-end, automated or interactive environments. SLCNV chains QC, CNV calling, segmentation, plotting and clustering for low-pass whole-genome sequencing in a containerized Nextflow/Docker pipeline. BUDDY combines alignments, structure viewing, pathogenicity predictions and CRISPR reagent design in a web platform for modeling human missense variants through S. cerevisiae orthologs. mobileRNA applies automated multi-genome alignment to identify mobile RNAs in grafted plants, validated on simulated grafts. Vizitig shifts the unit of analysis to colored de Bruijn graphs, enabling interactive querying across samples for pangenome and pantranscriptome work. What is new here is the integration layer itself: packaged workflows for sequencing-derived copy number analysis, cross-tool assembly of alignment, structure and reagent design for variant functional modeling, and graph-based cross-sample exploration.
Published papers
mobileRNA: an integrative, automated tool for accurate identification of mobile RNA molecules based on multiple genome mapping.
mobileRNA is an automated multi-genome alignment pipeline for identifying mobile RNAs in grafted plants, validated on simulated grafts and assessed with a…
The Vizitig pangenome and pantranscriptome explorer.
Vizitig is a platform for interactive querying and visualization of colored de Bruijn graphs across samples, supporting pangenome and pantranscriptome analysis…
Preprints
Streamline CNV - A Handy Nextflow Pipeline for Chromosomal Copy Number Variation Analysis
Streamline CNV (SLCNV) is a Nextflow/Docker pipeline for low-pass WGS copy number analysis, covering QC, CNV calling, segmentation, plots, clustering, and…
BUDDY: An interactive web platform to accelerate the functional modeling of human missense variants using Saccharomyces cerevisiae orthologs
BUDDY is a web platform integrating alignments, structure viewing, pathogenicity predictions, CRISPR reagent design, and AI-assisted design to model human…
Topic history
| Date | Rank |
|---|---|
| #29 | |
| #34 | |
| #26 | |
| #34 | |
| #13 | |
| #36 | |
| #12 | |
| #26 | |
| #18 | |
| #39 | |
| #13 | |
| #28 | |
| #15 | |
| #11 | |
| #11 | |
| #11 | |
| #22 | |
| #1 | |
| #17 | |
| #22 | |
| #14 | |
| #14 | |
| #16 | |
| #6 | |
| #13 | |
| #8 | |
| #4 | |
| #3 | |
| #31 | |
| #34 | |
| #27 | |
| #20 | |
| #34 | |
| #30 | |
| #38 |